Mechanism of μ-Conotoxin PIIIA binding to the voltage-gated Na+ channel NaV1.4 by Chen, Rong et al.
Mechanism of m-Conotoxin PIIIA Binding to the
Voltage-Gated Na+ Channel NaV1.4
Rong Chen*, Anna Robinson, Shin-Ho Chung
Research School of Biology, Australian National University, Canberra, ACT, Australia
Abstract
Several subtypes of voltage-gated Na+ (NaV) channels are important targets for pain management. m-Conotoxins isolated
from venoms of cone snails are potent and specific blockers of different NaV channel isoforms. The inhibitory effect of m-
conotoxins on NaV channels has been examined extensively, but the mechanism of toxin specificity has not been
understood in detail. Here the known structure of m-conotoxin PIIIA and a model of the skeletal muscle channel NaV1.4 are
used to elucidate elements that contribute to the structural basis of m-conotoxin binding and specificity. The model of
NaV1.4 is constructed based on the crystal structure of the bacterial NaV channel, NaVAb. Six different binding modes, in
which the side chain of each of the basic residues carried by the toxin protrudes into the selectivity filter of NaV1.4, are
examined in atomic detail using molecular dynamics simulations with explicit solvent. The dissociation constants (Kd)
computed for two selected binding modes in which Lys9 or Arg14 from the toxin protrudes into the filter of the channel are
within 2 fold; both values in close proximity to those determined from dose response data for the block of NaV currents. To
explore the mechanism of PIIIA specificity, a double mutant of NaV1.4 mimicking NaV channels resistant to m-conotoxins and
tetrodotoxin is constructed and the binding of PIIIA to this mutant channel examined. The double mutation causes the
affinity of PIIIA to reduce by two orders of magnitude.
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Introduction
Voltage-gated sodium (NaV) channels play a vital role in cell
excitability. Several subtypes of NaV channels such as NaV1.3,
NaV1.7, NaV1.8 and NaV1.9 are involved in the pain pathway [1],
and thus are important targets for pain management. Many
polypeptide toxins isolated from venomous animals such as
scorpions, cone snails and spiders selectively interfere with the
gating mechanisms and ion conduction properties of certain
subtypes of NaV channels. These toxins are promising scaffolds for
novel pesticides and analgesics [2,3].
A family of peptide toxins isolated from venoms of cone snails,
referred to as m-conotoxins, are potent and selective blockers of
NaV channels. m-Conotoxins typically consist of 20–25 residues,
six of which are cysteines forming three disulfide bridges, known as
the inhibitor cystine knot [4,5]. Some among the most well-
characterized m-conotoxins are GIIIA [6], PIIIA [7], SmIIIA [8]
and KIIIA [9]. GIIIA and PIIIA selectively inhibit the skeletal
muscle channel NaV1.4 with IC50 (half-maximal inhibitory
concentration) values in the nanomolar range [7,10,11], and do
not inhibit neuronal channels NaV1.7 and NaV1.8 at a concen-
tration of 100 mM [12,13]. On the other hand, SmIIIA and KIIIA
inhibit NaV1.7 effectively at a concentration of 1 mM [12]. KIIIA
was found to ease inflammatory pain in mice [14]. Various
derivatives of KIIIA and other toxins have been designed [15–20],
in an attempt to improve their analgesic effect and pharmaco-
chemical properties. In particular, the R14A mutant of KIIIA was
found to be 10-fold selective for NaV1.7 over NaV1.2 and NaV1.4
[18], suggesting that in principle selective inhibitors of NaV1.7 can
be developed from m-conotoxins.
m-Conotoxins inhibit NaV channels via a pore-blocking
mechanism [21,22]. On binding to NaV channels, the side chain
of a basic residue from a toxin protrudes into the selectivity filter of
a channel, thereby inhibiting ion conduction. In the case of GIIIA,
an arginine at position 13 has been proposed to be the residue that
protrudes into the filter of the receptor channel [6], corresponding
to the arginine at position 14 of PIIIA [7,23]. Extensive
mutagenesis experiments performed on PIIIA show that the
mutation of each basic residue from the toxin to a neutral amino
acid causes the affinity of the toxin for NaV1.4 to decrease by 10 to
50 fold, corresponding to a change of +2 to +4 kT in the free
energy of binding [23,24]. The change in binding free energy due
to any of the charge-changing mutations is lower than the free
energy of 6–7 kT for a typical salt bridge [25,26], indicating that
none of the mutations completely disrupts the salt bridge between
the toxin and the channel pore.
Molecular dynamics (MD) simulations have been fruitfully used
to construct model structures of peptide toxins in complex with ion
channels such as K+ channels and the bacterial NaV channel
NaVAb [27–29]. Such models, once validated against experimen-
tal data, would provide insight into the molecular determinants for
the high-affinity and selective binding of a toxin to a channel,
which can then be used to guide the design of novel toxins with
improved potency and specificity. However, only few computa-
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tional studies on the binding of m-conotoxins to NaV channels have
been reported [18,23,30,31], largely due to the unavailability of
atomic structures for mammalian NaV channels.
Here the binding of m-conotoxin PIIIA to NaV1.4 is examined
in atomic detail using MD simulations. Complex structures of all
six possible binding modes of PIIIA-NaV1.4 are constructed using
MD simulations with distance restraints. Similar pattern of
interactions is observed in these complexes, suggesting that PIIIA
can inhibit NaV1.4 with multiple alternative binding modes. The
dissociation constant (Kd) of PIIIA-NaV1.4 binding measured
experimentally is reproduced within 5-fold using potential of mean
force (PMF) calculations. A double mutant ([N181R, E172Q]) of
NaV1.4 mimicking NaV channels resistant to tetrodotoxin (TTX)
and m-conotoxins is constructed. The Kd value is found to increase
by two orders of magnitude after the mutation, suggesting that
NaV1.4 can be made resistant to PIIIA by this double mutation.
Methods
Homology model of NaV1.4
A homology model of the human muscle sodium channel
NaV1.4 is generated using the 1836 amino acid sequence from the
protein database of National Center for Biotechnology Informa-
tion (Reference: NP_000325). Initially, seven partial models are
generated from the full sequence on four different structural
templates, including PDB IDs 2KBI [32], 2I53 [33], 3RW0 [34],
and 3G43 [35], using the homology modeling server SWISS-
MODEL [36]. Sequence identify of NaV1.4 segments with the
different ion channels varies between 15% and 77%. The models
are then visualized to determine how they correspond to the
transmembrane pore forming domains of the channel. Those parts
of NaV1.4 external to the pore forming domain are excluded from
this study. The crystal structure of the bacterial NaV channel
NaVAb [34], the filter of which is in the conductive state suitable
for toxins to bind, is used as a template for the final model. NaVAb
was used as a template in homology modeling of NaV1.4
previously [37]. Since the extracellular loops linking the S5, P1,
P2 and S6 helices are significantly longer in NaV1.4 than in
NaVAb, these loops cannot be modeled reliably on NaVAb.
Therefore, the sequence of NaV1.4 is then modified to remove
these loops (Fig. S1). The modified sequence is then used for
homology modeling. As the sequence identity between the
modified sequence and NaVAb is low (20–24%), structural
similarity between NaV1.4 and NaVAb must be assumed. The
four homologous domains of NaV1.4, referred to as domains I to
IV (DI, DII, DIII and DIV), are modeled as discrete subunits. For
DII, a second model is constructed on NaVRh, PDB ID 4DXW
[38], and the resulting structure is found to be similar to that
modeled on NaVAb (root mean square deviation 1.6 A˚). This
second model appears to align better with the other domains and
thus is used in the final model. Each of the four domains generated
comprises of the S5, P1, selectivity filter, P2 and S6 structural
elements. Ramachandran plots show that more than 97% of the
backbone dihedral angles are within favored or allowed regions.
To configure the four-fold symmetry of the ion-channel, the four
domains of NaV1.4 are aligned with NaVAb clockwise [39,40].
The backbones of these two channels virtually superimpose (Fig.
S2). The DEKA ring in the selectivity filter of NaV1.4 corresponds
to the positions of the equivalent EEEE (NaVAb) and SSSS
(NaVRh) rings in bacterial NaV channels. The resulting ion
channel has a pore radius of 2.5 A˚.
Molecular dynamics simulations
The NaV1.4 channel is embedded in a POPC (2-oleoyl-1-
palmitoyl-sn-glycero-3-phosphocholine) bilayer built in VMD [41].
The simulation box contains the channel protein, 172 lipids, 68
Na+ ions, 59 Cl2 ions and 15,743 water molecules. The
concentration of NaCl is approximately 0.2 M. The system is
equilibrated extensively for 50 ns, and the size of the simulation
box evolves to about 856856100 A˚3 at the end of the simulation
(Fig. S2). In the first 20 ns of the equilibration during which the
inner cavity of the channel becomes fully hydrated, a harmonic
restraint is applied to maintain a rigid channel backbone. At 20 ns,
a Na+ ion in the bulk is manually moved into the filter. Without
the presence of this Na+ ion the side chain of Lys177 would
spontaneously reorient and occlude the ion conduction pathway,
consistent with the results of Xia et al. [42]. Subsequently the
harmonic restraint is released and the system simulated for a
further 30 ns without any restraints. The structure of the channel
is stable, as evidenced by the fact that the root mean square
deviation of the channel backbone with reference to the initial
energy-minimized model fluctuates between 2 and 3 A˚ over the
last 20 ns.
Toxin PIIIA is then added to the system, with its center of mass
(COM) 40 A˚ above the COM of the channel, such that the toxin is
not in direct contact with any part of the channel. The solution
structure for PIIIA (PDB ID 1R9I) is used [43]. The toxin carries a
net charge of +6 e, as histidine which adopts predominantly the
deprotonated form at the physiological pH of 7.4 is assumed to be
neutral. Six Na+ ions are removed to maintain charge neutrality.
To accelerate the binding of the toxin to the channel, a flat-bottom
harmonic distance restraint is applied to the side chain nitrogen
atom of a basic residue of the toxin and the center of the carbonyl
groups of residues 176 of the channel filter. This method has been
successfully applied to several similar systems previously [44–46].
The upper boundary of the distance restraint is gradually
decreased from 15 to 3 A˚ over a simulation period of 5 ns, such
that the chosen basic residue of the toxin is drawn into the filter.
The simulation is continued further for 15 ns with the harmonic
restraints removed. To improve sampling each simulation is
repeated a second time with a different orientation for the toxin.
MD simulations are performed at 1 atm and 300 K using
NAMD 2.9 [47] with periodic boundary conditions applied. The
CHARMM36 force field and the TIP3P model for water are used
to describe the interatomic interactions [48–50]. The switch and
cutoff distances for short-range non-bonded interactions are 8.0 A˚
and 12.0 A˚, respectively. The particle mesh Ewald method is used
to account for long-range electrostatic interactions, with a
maximum grid spacing of 1.0 A˚. The SHAKE [51] and SETTLE
[52] algorithms are used to keep the bond lengths in the system
rigid. A time step of 2 fs is used. Trajectories are saved every 20 ps
for analysis. Molecular graphics are generated using VMD [41].
Umbrella sampling
The umbrella sampling method is used to construct the PMF
profile for the unbinding of PIIIA from NaV1.4 along the channel
axis. Based on the PMF profile the Kd value for the formation of
the toxin-channel complex can be calculated rigorously according
to eq. 1 [27]. It is worth noting that Kd and IC50 have been used
interchangeably as it may be assumed that the experimentally
measured IC50 and the true Kd values are in the same order.
A constant force of 20 kcal mol21 A˚21 is applied to pull the
toxin out from the binding site, allowing the starting structures of
the umbrella windows spaced at 0.5 A˚ intervals to be generated.
The backbones of both the toxin and the channel are maintained
rigid during the pulling. The COM of the toxin backbone is
PIIIA Binding to NaV1.4
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restrained to the center of each umbrella window using a
harmonic force constant of 30 kcal mol21 A˚22. The COM of
the channel is at z= 0 A˚. A flat-bottom harmonic restraint is
applied to maintain the COM of the toxin backbone within a
cylinder of 8 A˚ in radius centered on the channel axis. The toxin is
allowed to move freely in the plane perpendicular to the channel
axis within this cylinder. Each umbrella window is simulated for
up to 8 ns until the PMF profile changes by less than 0.5 kT in
depth over the last 1 ns. The first 1 ns of each window are
removed from data analysis. The z coordinate of the toxin COM is
saved every 1 ps for analysis.
Data analysis
A salt bridge is assumed to have formed if the distance is less
than 4 A˚ between a side chain oxygen atom from an acidic residue
and a side chain nitrogen atom from a basic residue [53]. A
hydrogen bond is assumed to be formed if the donor and acceptor
atoms (nitrogen or oxygen) are within 3.0 A˚ of each other and the
donor-hydrogen-acceptor angle is $150u [54]. The length of a salt
bridge is defined as the distance between the COM of the oxygen
atoms in the side chain of the acidic residue and COM of the
nitrogen atoms in the side chain of the basic residue. The weighted
histogram analysis method is used to construct the PMF profile
[55]. The Kd value is derived using the following equation [27]:
Kd
{1
~1000pR2NA
ðzmax
zmin
exp½{W (z)=kT dz ð1Þ
where R is the radius of the cylinder (8 A˚), NA is Avogadro’s
number, zmin and zmax are the boundaries of the binding site along
the channel axis (z), and W(z) is the PMF.
Results and Discussion
Outer vestibule of NaV1.4
A homology model of the pore domain of NaV1.4 is constructed
based on the sequence alignment displayed in Fig. 1A (details
given in the Methods section). The model of NaV1.4 shows that
there is an outer ring of acidic residues at positions 180 of DI, DII
and DIV and 181 of DIII just outside the filter (Fig. 1B). In
addition, two acidic residues at positions 184 and 187 of DII are
also in close proximity to the filter. These negatively-charged
residues may form strong electrostatic interactions with m-
conotoxins which typically carry several positively-charged basic
residues. Thus, our model of NaV1.4 is consistent with the high-
affinity inhibition of NaV1.4 by m-conotoxins observed experi-
mentally. We demonstrate below that our model of NaV1.4 allows
both the binding affinity and the selectivity of PIIIA for NaV1.4
measured experimentally to be reproduced.
Selectivity filter of NaV1.4
The selectivity filter of NaV1.4 carries a DEKA ring (Fig. 1A), as
opposed to the EEEE ring found in NaVAb and voltage-gated
Ca2+ (CaV) channels. This feature of NaV1.4 may have important
implications for its ion conduction mechanism. After 50 ns of
simulation, one Na+ ion is present in close proximity to the
aspartate residue of the DEKA ring (Fig. 2A). The orientation of
Lys177 side chain is stabilized by the two salt bridges it forms with
the acidic residues at position 180 of DI and DIV, consistent with
a recent study [42]. A second Na+ ion is found near the outer ring
of acidic residues just outside the filter (Fig. 2A).
Structure of PIIIA
PIIIA is a small peptide consisting of 22 residues. The primary
structure of PIIIA is PcaRLCC-GFOKS-CRSRQ-CKOHR-CC,
where Pca and O indicate pyroglutamate and hydroxyproline,
respectively. The C-terminus of PIIIA is amidated and the overall
charge of PIIIA is +6 e at neutral pH resulting from the six basic
residues it carries. Fig. 2B shows that these six residues are
approximately coplanar and symmetrically distributed around the
globular surface of the toxin. This symmetry may be important for
the high-affinity binding of PIIIA to NaV channels. For example,
we show below that PIIIA can use each of the six basic residues it
carries to occlude the selectivity filter of NaV1.4, similar to that
observed previously for NaVAb [29].
Binding modes of PIIIA to NaV1.4
To predict the most favorable structures of PIIIA in complex
with NaV1.4, we use MD simulations with distance restraints
applied during the first 5 ns, as described in the Methods section.
This method allows us to examine all the possible binding modes
between the toxin and the channel with affordable computational
cost. Two distinct binding modes, in which Lys9 and Arg14 of
PIIIA occlude the selectivity filter of NaV1.4, respectively, are
considered initially. For each binding mode, two simulations
started from different initial configuration are performed to
improve sampling. Based on the number of salt bridges and
hydrogen bonds formed in the toxin-channel complex, the
simulation predicting the more favorable structure for each
Figure 1. Sequence and structure of NaV1.4. (A) Sequence
alignment of NaVAb and the four domains (I–IV) of NaV1.4 in the pore
domain. (B) The outer vestibule of NaV1.4 viewed from the extracellular
side along the channel axis. For simplicity the numbering of NaVAb is
used for NaV1.4.
doi:10.1371/journal.pone.0093267.g001
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binding mode is considered as representative and discussed in
detail below.
First we look at the simulation in which a distance restraint is
applied to Lys9 of PIIIA and the selectivity filter of NaV1.4 over
the first 5 ns. The distance restraint applied pulls the side chain of
Lys9 rapidly into the filter, whereas other residues of the toxin
interact favorably with the vestibular wall of the channel. Fig. 3A
shows that three salt bridges are formed at 8 ns and remain intact
for more than 10 ns during the remaining period of the
simulation, suggesting that the complex structure is stable and
well equilibrated. One of the three salt bridges (Lys9-Asp177) is
located inside the filter, whereas the other two salt bridges are on
the vestibular wall (Fig. 4 A and B). The Na+ ion inside the filter
moves toward the inner cavity of the channel after the binding of
PIIIA (Fig. 4A), possibly due to the repelling force from the
positive charge carried by Lys9 of PIIIA.
Next we look at the simulation in which Arg14 of PIIIA is
drawn into the filter of NaV1.4 by using a distance restraint. The
position of PIIIA relative to the outer vestibule of NaV1.4 is
displayed in Fig. 4 C and D. Four salt bridges are formed between
the toxin and the channel, of which one is inside the filter and
three on the vestibular wall. The salt bridge in the filter, Arg14-
Glu180, is relatively weak, with its length longer than 4 A˚ most of
the times (Fig. 3B). The three salt bridges on the vestibular wall, on
the other hand, being less than 3.5 A˚ in length, are relatively
strong. Although Arg14 of PIIIA does not form a strong salt bridge
with the filter, the position of Arg14 with respect to the filter of the
channel appears to be stable.
In the two binding modes discussed above, the toxin-channel
complexes are stabilized by three or four salt bridges, whereas the
filter residue (Lys9 or Arg14) protrudes deeply into the filter in
both modes (Fig. 4). In these two binding modes the toxin interacts
intimately with either DI-Glu180 or DII-Glu180, both of which
have been shown experimentally to be important for the binding
of a closely-related toxin, GIIIA [56]. Similar toxin-channel
interactions are observed in all the other four possible binding
modes, in which Arg2, Arg12, Lys17 or Arg20 of PIIIA protrudes
into the filter of NaV1.4, predicted from MD simulations with
distance restraints. In all the four modes, the toxin is able to form
three or four salt bridges with the channel (Fig. S3), consistent with
the Lys9 and Arg14 binding modes we observed (Fig. 4). Thus, the
six binding modes of PIIIA-NaV1.4 may be of similar energetics.
Subsequent PMF calculations are consistent with this proposal.
PMF profiles
To validate the binding modes of PIIIA-NaV1.4 predicted from
MD simulations, we construct the PMF profile for the dissociation
of the toxin from each complex along the channel axis (z). Based
on the PMF profile, the corresponding Kd value is calculated
according to eq. 1 and compared to experiment. Due to the
limited computational resource available, we derive PMF profiles
for the selected two binding modes, in which Lys9 or Arg14 is the
filter residue. The Arg14 mode is considered because it has been
proposed as the predominant mode in previous experimental
studies [23]. The PMF for the Lys9 mode is derived to illustrate
that a binding mode equally favorable to the Arg14 mode exists.
For the Lys9 mode, extra umbrella windows are added at
z= 23.8 A˚ and z= 25.2 A˚ to ensure good overlap between
umbrella windows. Fig. S4 shows the convergence of the PMF
profiles. The converged PMF profiles for the two binding modes in
which Lys9 or Arg14 of PIIIA protrudes into the filter of NaV1.4
are displayed in Fig. 5. No significant differences in the two profiles
are evident, indicating that the two binding modes are of similar
energetics.
The depth of the PMF profile for the Lys9 mode is 17.6 kT,
close to the value of 17.8 kT for the Arg14 mode. The Kd values
computed are 300 nM and 150 nM for the Lys9 and Arg14
modes, respectively. Experimentally the Kd value for the binding of
PIIIA to rat NaV1.4, which is identical to human NaV1.4 in the
pore loops, has been estimated to be in the range of 36 nM to
200 nM [12,23,30]. Therefore, the Kd values predicted from PMF
calculations do not differ dramatically from those determined
experimentally.
Figure 2. Ion binding site of NaV1.4 and structure of PIIIA. (A)
The selectivity filter of NaV1.4 with two Na
+ ions (yellow spheres)
bound. (B) Molecular structure of PIIIA with the side chains of six basic
residues highlighted in blue.
doi:10.1371/journal.pone.0093267.g002
Figure 3. Time evolution of the lengths of the salt bridges in
two MD simulations. A distance restraint is applied to Lys9 (A) or
Arg14 (B) of PIIIA and the filter of NaV1.4 over the first 5 ns of each
simulation.
doi:10.1371/journal.pone.0093267.g003
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We note here that the two PMF profiles we derived are biased.
In other words, the umbrella sampling simulations over a limited
simulation time only explore a narrow configurational space. In
real systems, the toxin would bind with different modes each
contributing to an unbiased PMF. The unbiased PMF is reflected
in the Kd value measured experimentally. The fact that the Kd
values derived from the two biased PMF profiles are in good
agreement with the experimental Kd value suggests that the true
unbiased PMF profile is similar to the biased PMF profiles we
derived (Fig. 5).
Various factors can contribute to the uncertainty in the
predicted Kd values. The accuracy of the force field and molecular
models, and the search of configurational space during umbrella
sampling largely determine the systematic error, whereas approx-
imating a PMF profile from umbrella sampling simulations can
cause random errors. The random errors can be derived, e.g.,
from bootstrapping methods, while the systematic error can only
be estimated by comparing the Kd values predicted to that
determined experimentally. Numerous studies performed on pore
blockers of K+ channels showed that the systematic error was
generally less than 3 kT [27,28]. However, the systematic error for
the PMF profiles in Fig. 5 could be higher, due to the uncertainty
in the model of the channel. Also, the hetero-tetrameric nature of
NaV1.4 poses difficulties in the sampling of the configurational
space. Nevertheless, the overall error for the PMF profiles of
PIIIA-NaV1.4 is found to be low, possibly because errors from
different sources cancel out.
A NaV1.4 double mutant
Several isoforms of NaV channels (NaV1.5, NaV1.8 and NaV1.9)
are resistant to TTX and m-conotoxins [12,57]. NaV1.5 is
important for heart function [58], whereas NaV1.8 and NaV1.9
are involved in the perception of pain [1]. Sequence alignment
shows that all these three channels differ from NaV1.4 at two
positions, namely, position 181 of DI and position 172 of DIV
(Fig. 6). At position 181 of DI, it is a neutral asparagine in NaV1.4,
in contrast to a positively charged lysine or arginine in TTX-
resistant channels. At position 172 of DIV, it is a negatively
charged glutamate in NaV1.4, and a neutral glutamine in TTX-
resistant channels. These two residues are in close proximity to
each other, as illustrated in Fig. 1B. A double mutant of NaV1.4
(DI-N181R, DIV-E172Q) is constructed to ascertain the role of
these two residues in the selectivity of PIIIA for NaV1.4. We show
that the mutation causes the Kd value for the binding of PIIIA to
the channel to increase by two orders of magnitude, suggesting the
importance of residues DI-Asn181 and DIV-Glu172 for the
selectivity of PIIIA for NaV1.4 over TTX-resistant NaV channels.
Computational mutagenesis is performed on the PIIIA-NaV1.4
complex in which toxin Arg14 protrudes into the filter of the
channel. DI-Asn181 and DIV-Glu172 are replaced with an
arginine and a glutamine, respectively, resulting in a net loss of -2 e
in charge to the outer vestibule of the channel. Considering that
PIIIA is positively charged, the mutant channel is expected to have
a lower affinity for the toxin. Two Na+ ions are removed from the
Figure 4. Structures of PIIIA in complex with NaV1.4 predicted from MD simulations biased with distance restraints. In two binding
modes of PIIIA-NaV1.4, Lys9 (A and B) and Arg14 (C and D) of the toxin protrudes into the filter of the channel, respectively. In (A) and (C), the Na
+ ion
inside the filter is shown as a yellow sphere. Toxin backbone is in yellow and channel backbone in grey.
doi:10.1371/journal.pone.0093267.g004
Figure 5. The PMF profiles for the dissociation of PIIIA from
NaV1.4. The profile for PIIIA binding to a [DI-N181R, DIV-E172Q] double
mutant of NaV1.4 is also shown. The reaction coordinate z is the
distance between the centers of mass of toxin and channel backbones
along the channel axis. The random errors of the PMF profiles estimated
from the bootstrapping method are less than 0.5 kT in all cases.
doi:10.1371/journal.pone.0093267.g005
PIIIA Binding to NaV1.4
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bulk to maintain charge neutrality. The complex is equilibrated for
10 ns in an unbiased MD simulation. The salt bridge Lys9-Asp161
is broken but an equivalent salt bridge, Arg20-Glu187, is formed
after the equilibration. Although the same number of salt bridges is
present in the structures of PIIIA in complex with the wild type
and mutant NaV1.4, the binding affinity is found to decrease
substantially after the mutation. Thus, the two residues mutated
influence the binding affinity primarily via long-range electrostatic
interactions with the toxin, and should have similar effects on
different binding modes of the toxin and the channel. The PMF
profile for the mutant channel, 12 kT in depth, predicts a Kd
value of 20 mM (Fig. 5). The mutant NaV1.4 binds PIIIA about
100 fold less effectively than the wild type, suggesting that the two
residues (DI-Asn181 and DIV-Glu172) are important for toxin
selectivity.
Conclusions
In this work the binding of m-conotoxin PIIIA to a homology
model of the voltage-gated sodium channel NaV1.4 is examined
using MD simulations. Six binding modes, in which any of the six
basic residues carried by PIIIA protrudes into the selectivity filter
of NaV1.4, are considered. In all the binding modes the toxin-
channel complex is stabilized by three or four salt bridges. PMF
calculations predict Kd values of 300 and 150 nM for the Lys9 and
Arg14 modes, respectively, in close proximity to the experimental
values of 36–200 nM [12,23,30]. Thus, our simulations suggest
that PIIIA can inhibit NaV1.4 with multiple alternative binding
modes of similar energetics. Further studies would be required to
determine whether or not the multiple-binding-mode mechanism
of PIIIA can be generalized to other m-conotoxins such as GIIIA,
for which one predominant binding mode to NaV1.4 has been
suggested [59,60].
The multiple binding modes of PIIIA to NaV1.4 uncovered here
is consistent with the extensive mutagenesis experiments of
McArthur et al. [24]. For example, it was found that the mutation
of Arg14 to an alanine or glutamate reduces the affinity of PIIIA
by only 11 fold, corresponding to a change of 2.4 kT in the
binding free energy, substantially lower than the free energy of 6–
7 kT for a typical salt bridge [25,26]. In addition, the alanine
mutation of several other basic residues, such as Arg2, Arg12 and
Lys17, causes similar reduction in the toxin’s binding affinity
[23,24]. The substitution of Lys8 in GIIIA, which corresponds to
Lys9 in PIIIA, to a glutamine, also causes the toxin affinity to
decrease by only 7 fold [10]. The similar effect of different
mutations observed experimentally support a multiple-binding-
mode mechanism by PIIIA. When a basic residue of the toxin is
mutated to an alanine, only one of the several binding modes is
disrupted. As such each charge-changing mutation causes a similar
reduction in binding affinity by the removal of a positive charge.
Different isomers of PIIIA having similar affinities for NaV1.4 may
adopt distinct binding modes to the channel [30], suggesting that a
unique binding mode is inadequate to describe PIIIA binding to
NaV channels.
Experimental studies have found that several residues from
DII and DIII of NaV channels are important for the specificity of
m-conotoxins [18,61,62]. Experimental data have also suggested
that DI-Asn181 might be involved in m-conotoxin specificity [63].
Here it is shown that residues DI-Asn181 and DIV-Glu172
are important for the selectivity of PIIIA for NaV1.4 over
TTX-resistant NaV channels. As DI-Asn181 is replaced by a
basic residue in TTX-resistant channels, one or more acidic
residues may be introduced into the toxin to improve the affinity
of the toxin for these channels. In fact, all known m-conotoxins
such as SmIIIA, KIIIA and BuIIIA with a Kd value for NaV1.5
in the micromolar range carry one or more acidic residues [4,
12].
Supporting Information
Figure S1 Primary structure of human NaV1.4. The
selectivity filter region is in purple and other regions of the pore
domain included in homology modeling are highlighted in yellow.
Regions of the pore domain not modeled are in grey.
(TIF)
Figure S2 (A) Structural alignment between NaVAb (red)
and the four domains of our NaV1.4 model (blue). (B) The
position of NaV1.4 model (purple ribbons) relative to the lipid
bilayer viewed perpendicular to the bilayer normal is shown on the
left. The view along the bilayer normal from the extracellular side
is shown on the right (for channel protein color scheme is as
follows: green, polar; white, hydrophobic; blue, basic; red, acidic).
Yellow spheres indicate lipid phosphorus atoms. Blue lines indicate
the boundary of the simulation box. Water molecules and ions are
not shown for clarity.
(TIF)
Figure S3 Structures of toxin PIIIA (yellow ribbons) in
complex with NaV1.4 (gray ribbons) in which the side
chains of Arg2 (A), Arg12 (B), Lys17 (C) and Arg20 (D)
protrude into the filter of the channel. In (D), Arg2 from
PIIIA is in close contact with DIII-Asp161. The complex
structures are predicted from MD simulations biased with distance
restraints.
(TIF)
Figure S4 Block analysis of the PMF profiles for the
Lys9 mode (A) and the Arg14 mode (B).
(TIF)
File S1 PDB coordinate files of NaV1.4 model and
NaV1.4 in complex with PIIIA.
(ZIP)
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